Frailty Risks of Prescription Analgesics and Sedatives across Frailty Models: the Health and Retirement Study
Tóm tắt
Limited evidence for incident frailty risks associated with prescription analgesics and sedatives in older (≥ 65 years) community-living adults prompted a more comprehensive investigation. We used data from older Health and Retirement Study respondents and three frailty models (frailty index, functional domain, frailty phenotype with 8803, 10,470, and 6850 non-frail individuals, respectively) and estimated sub-hazard ratios of regular prescription drug use (co-use, analgesic use, and sedative use), by frailty model. We addressed confounding with covariate adjustment and propensity score matching approaches. The baseline prevalence of analgesic and sedative co-use, analgesic use, and sedative use among non-frail respondents was 1.8%, 12.8%, and 4.7% for the frailty index model, 4.2%, 16.2%, and 5.3% for the functional domain model, and 4.3%, 15.4%, and 6.1% for the frailty phenotype model, respectively. Cumulative frailty incidence over 10 years was 39.3%, 36.1%, and 14.2% for frailty index, functional domain, and frailty phenotype models, respectively; covariate-adjusted sub-hazard ratio estimates were 2.00 (1.63–2.45), 1.83 (1.57–2.13), and 1.68 (1.21–2.33) for co-use; 1.72 (1.56–1.89), 1.38 (1.27–1.51), and 1.51 (1.27–1.79) for analgesic use; and 1.46 (1.24–1.72), 1.25 (1.07–1.46), and 1.31 (0.97–1.76) for sedative use. Frailty risk ranking (co-use > analgesic use > sedative use) persisted across all model sensitivity analyses. Consistently significant frailty risk estimates of regular prescription analgesic and sedative co-use and of prescription analgesic use support existing clinical, public health, and regulatory guidance on opioid and benzodiazepine co-prescription, on opioid prescription, and on NSAID prescription. Frailty phenotype measurement administration limited power to detect significant frailty risks. Research into specific pharmaceutical exposures and comparison of results across cohorts will be required to contribute to the deprescribing evidence base.
Tài liệu tham khảo
Howlett SE, Rutenberg AD, Rockwood K. The degree of frailty as a translational measure of health in aging. Nature Aging. 2021;1:651–65.
Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998;53:S9-16.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–56.
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95.
Palmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, On behalf of the European Geriatric Medicine Society Pharmacology special interest group, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10:9–36.
Mangin D, Bahat G, Golomb BA, Mallery LH, Moorhouse P, Onder G, et al. International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35:575–87.
Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20:S3–92.
Pop P, Bronskill SE, Piggott KL, Stall NM, Savage RD, Visentin JD, et al. Management of sleep disorders in community-dwelling older women and men at the time of diagnosis. J Am Geriatr Soc. 2019;67:2094–101.
Albrecht JS, Wickwire EM, Vadlamani A, Scharf SM, Tom SE. Trends in insomnia diagnosis and treatment among medicare beneficiaries, 2006–2013. Am J Geriatr Psychiatry. 2019;27:301–9.
Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE Randomized Clinical Trial. JAMA. 2018;319:872–82.
Wright SL. Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review. Adv Ther. 2020;37:2604–19.
Braden JB, Young A, Sullivan MD, Walitt B, Lacroix AZ, Martin L. Predictors of change in pain and physical functioning among post-menopausal women with recurrent pain conditions in the women’s health initiative observational cohort. J Pain. 2012;13:64–72.
Gerlach LB, Olfson M, Kales HC, Maust DT. Opioids and other central nervous system-active polypharmacy in older adults in the United States. J Am Geriatr Soc. 2017;65:2052–6.
Montero-Odasso M, Sarquis-Adamson Y, Song HY, Bray NW, Pieruccini-Faria F, Speechley M. Polypharmacy, gait performance, and falls in community-dwelling older adults. Results from the gait and brain study. J Am Geriatr Soc. 2019;67:1182–8.
Watanabe JH, Yang J. Hospitalization and combined use of opioids, benzodiazepines, and muscle relaxants in the United States. Hosp Pharm. 2020;55:286–91.
Cadet C, Maheu E. Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: prescribe or proscribe? Ther Adv Musculoskelet Dis. 2021;13:1759720X2110221.
George C, Verghese J. Polypharmacy and gait performance in community-dwelling older adults. J Am Geriatr Soc. 2017;65:2082–7.
George CJ, Verghese J, Izzetoglu M, Wang C, Holtzer R. The effect of polypharmacy on prefrontal cortex activation during single and dual task walking in community dwelling older adults. Pharmacol Res. 2019;139:113–9.
Ghachem A, Fried LP, Legault V, Bandeen-Roche K, Presse N, Gaudreau P, et al. Evidence from two cohorts for the frailty syndrome as an emergent state of parallel dysregulation in multiple physiological systems. Biogerontology. 2020;20:63–79.
Chang S-F, Cheng C-L, Lin H-C. Frail phenotype and disability prediction in community-dwelling older people: a systematic review and meta-analysis of prospective cohort studies. J Nurs Res. 2019;27: e28.
Chang S-F, Lin P-L. Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies. Int J Nurs Stud. 2015;52:1362–74.
Cil G, Park J, Bergen AW. Self-reported prescription drug use for pain and for sleep and incident frailty. J Am Geriatr Soc. 2019;67:2474–81.
Corrigendum. J Am Geriatr Soc. 2020;68: E50–E53.
Roberto A, Greco MT, Uggeri S, Cavuto S, Deandrea S, Corli O, et al. Living systematic review to assess the analgesic undertreatment in cancer patients. Pain Pract. 2022;22:487–96.
Cigolle CT, Ofstedal MB, Tian Z, Blaum CS. Comparing models of frailty: the Health and Retirement Study. J Am Geriatr Soc. 2009;57:830–9.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496.
Kennedy J, Roll JM, Schraudner T, Murphy S, McPherson S. Prevalence of persistent pain in the U.S. adult population: new data from the 2010 national health interview survey. J Pain. 2014;15:979–84.
Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399–424.
Saraiva MD, Suzuki GS, Lin SM, de Andrade DC, Jacob-Filho W, Suemoto CK. Persistent pain is a risk factor for frailty: a systematic review and meta-analysis from prospective longitudinal studies. Age Ageing. 2018;47:785–93.
Herr KA, Spratt K, Mobily PR, Richardson G. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain. 2004;20:207–19.
Rhee TG. Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends. J Gerontol A Biol Sci Med Sci. 2019;74:1910–5.
Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999–2015. JAMA Netw Open. 2020;3: e2028557.
Rochon PA, Stall NM, Holmes HM. Drug therapy and frailty: chicken or the egg? J Am Geriatr Soc. 2019;67:2441–3.
Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263–76.
Blodgett J, Theou O, Kirkland S, Andreou P, Rockwood K. Frailty in NHANES: comparing the frailty index and phenotype. Arch Gerontol Geriatr. 2015;60:464–70.
Arnadottir SA, Bruce J, Lall R, Withers EJ, Underwood M, Shaw F, et al. The importance of different frailty domains in a population based sample in England. BMC Geriatr. 2020;20:16.
Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R, et al. Frailty in older adults: a nationally representative profile in the United States. J Gerontol A Biol Sci Med Sci. 2015;70:1427–34.
Levy H, Weir DR. Take-up of medicare Part D: results from the Health and Retirement Study. J Gerontol B Psychol Sci Soc Sci. 2010;65:492–501.
Zhang M-J, Fine J. Summarizing differences in cumulative incidence functions. Stat Med. 2008;27:4939–49.
Aliberti MJR, Cenzer IS, Smith AK, Lee SJ, Yaffe K, Covinsky KE. Assessing risk for adverse outcomes in older adults: the need to include both physical frailty and cognition. J Am Geriatr Soc. 2019;67:477–83.
Grol-Prokopczyk H. Use and opinions of prescription opioids among older american adults: sociodemographic predictors. J Gerontol B Psychol Sci Soc Sci. 2019;74:1009–19.
Cigolle CT, Nagel CL, Blaum CS, Liang J, Quiñones AR. Inconsistency in the self-report of chronic diseases in panel surveys: developing an adjudication method for the health and retirement study. J Gerontol B Psychol Sci Soc Sci. 2018;73:901–12.
Lohman MC, Whiteman KL, Greenberg RL, Bruce ML. Incorporating persistent pain in phenotypic frailty measurement and prediction of adverse health outcomes. J Gerontol A Biol Sci Med Sci. 2017;72:216–22.
Grol-Prokopczyk H. Sociodemographic disparities in chronic pain, based on 12-year longitudinal data. Pain. 2017;158:313–22.
Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62:738–43.